未登录

D

Dmitriy Minond

Nova Southeastern University

H指数:25

被引数:1,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RNA-Binding Motif Protein 3 as a Therapeutic and Prognostic Target for Drug Discovery

RNA结合基序蛋白3作为药物发现的治疗和预后靶点

Current Issues in Molecular Biology

IF3

2026-08-130

OA

Probing APP Cleavage and Amyloid-β Assembly via Synthetic MUC-Type O-Glycosylated APP Glycopeptides

通过合成的MUC型O-糖基化APP糖肽探查APP切割和淀粉样β组装

ACS Chemical Neuroscience

IF3.9

2026-02-250

PRE

Modulation of Spliceosomal Proteins hnRNPH1 and H2 Increases Melanoma Cell Pro-Inflammatory Signaling In Vitro

剪接体蛋白hnRNPH1和H2的调控增加黑色素瘤细胞促炎信号通路（体外）

Biomolecules 2025, Vol. 15, Page 1611

IF4.8

2025-11-180

OAAI

An ADAM10 Exosite Inhibitor Is Efficacious in an In Vivo Collagen-Induced Arthritis Model

PHARMACEUTICALS

IF4.8

2024-01-091

OAAI

Downregulation of spliceosomal proteins hnRNPH1 and H2 in WM266-4 melanoma cells induces immune signaling

CANCER RESEARCH

IF16.6

2023-04-140

PRE

Assay-ready tissue-engineered cancer microspheres for high-throughput screening

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Novel melanoma leads demonstrate efficacy in A375 xenograft model in nude mice

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Droplet Microfluidics-Based Fabrication of Monodisperse Poly(ethylene glycol)-Fibrinogen Breast Cancer Microspheres for Automated Drug Screening Applications

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2022-08-1512

OAAI

Mucin-Type O-Glycosylation Proximal to β-Secretase Cleavage Site Affects APP Processing and Aggregation Fate

FRONTIERS IN CHEMISTRY

IF4.2

2022-04-083

OAAI

Tyrosine O-GalNAc Alters the Conformation and Proteolytic Susceptibility of APP Model Glycopeptides

ACS CHEMICAL NEUROSCIENCE

IF3.9

2021-07-298

OAAI

Discovery and Optimization of Selective Inhibitors of Meprin α (Part I)

PHARMACEUTICALS

IF4.8

2021-02-283

OAAI

Discovery and Optimization of Selective Inhibitors of Meprin α (Part II)

PHARMACEUTICALS

IF4.8

2021-02-275

OAAI

Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2020-05-065

OAAI

Exploring the Role of Amyloid-Beta Precursor Protein (APP) O -Glycosylation in Alzheimers Disease

IF4.2

2020-04-180

OA

Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases

IF3.9

2017-09-1524

PREAI

Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation

MEDIATORS OF INFLAMMATION

IF4.2

2017-01-01128

OAAI

Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate

SCIENTIFIC REPORTS

IF3.9

2016-12-0535

OAAI

Multicomponent assembly of 4-aza-podophyllotoxins: A fast entry to highly selective and potent anti-leukemic agents

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2015-12-0122

PREAI

SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2015-08-0417

OAAI

Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2014-11-1134

OAAI